Diabetes, obesity, and cardiovascular disease—what is the impact of lifestyle modification?
- 14.03.2025
- Main topic
Erschienen in:
- Verfasst von
- Celina Seth
- Veronika Schmid
- Stephan Mueller
- Mark Haykowsky
- Stephen J. Foulkes
- Martin Halle
- PD Dr. Dr. Simon Wernhart
- Erschienen in
- Herz | Ausgabe 4/2025
Abstract
Diabetes, obesity, and cardiovascular disease (CVD) represent an escalating global health challenge, contributing significantly to morbidity, mortality, and healthcare costs. Evidence from large cohort studies and clinical trials underscores the impact of diabetes and obesity as major risk factors for CVD, causing systemic inflammation, insulin resistance, and neurohormonal activation. Frequently, a sedentary lifestyle and unbalanced dietary habits are associated with these risk factors. Physical activity and exercise training interventions, a Mediterranean and plant-based diet, smoking cessation, and reduction of alcohol have shown promise in mitigating these risks. The implementation of lifestyle and pharmacotherapy have emerged as new pillars of preventive medicine. This review discusses the evidence of lifestyle interventions to reduce the burden of diabetes, obesity, and CVD. It is highlighted that only a multifaceted, sustained approach integrating lifestyle interventions and pharmacological strategies can reduce the burden of disease and improve long-term outcomes.
Anzeige
- Titel
- Diabetes, obesity, and cardiovascular disease—what is the impact of lifestyle modification?
- Verfasst von
-
Celina Seth
Veronika Schmid
Stephan Mueller
Mark Haykowsky
Stephen J. Foulkes
Martin Halle
PD Dr. Dr. Simon Wernhart
- Publikationsdatum
- 14.03.2025
- Verlag
- Springer Medizin
- Erschienen in
-
Herz / Ausgabe 4/2025
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692 - DOI
- https://doi.org/10.1007/s00059-025-05309-x
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
